13.11.2012 Business Update & Director Resignations
19.07.2012 Merger proposal Terminated
12.07.2012 New Director Appointed
10.07.2012 Share Placement Completed
1.05.2012 Progress with Investment in RTG
12.01.2012 Genesis to Merge with Mariposa Health
20.10.2011 G Chin Resignation
18.10.2011 Update re Discussions with UBNZ
14.03.2011 Board Changes
28.02.2011 Preliminary Financial Results
1.02.2011 Quarterly Cash Flow report
29.10.2010 Quarterly Cash Flow Report
29.09.2010 Half Year Report
24.09.2010 Cash Settlement Received
30.08.2010 Half Year Results
30.06.2010 Presentation to shareholders at annual meeting
29.06.2010 Share Placement Completed
15.06.2010 Share Placement
3.05.2010 Genesis Suspends NZ Operations
1.03.2010 Audited Financial statements
12.02.2010 Share Purchase Plan Letter and Offer Document
Share Purchase Plan Application Form
4.02.2010 Share Purchase Plan
4.02.2010 Preliminary Unaudited Financial Results for year ended 31 December 2009
3.11.2009 New Publication on detection of siRNA-mediated mRNA cleavage in vivo
16.10.2009 Notice of Meeting Addendum and Revised Proxy Form
12.8.2009 Share Purchase Plan Oversubscribed
7.8.2009 Half Year Results
5.8.2009 Letter to Shareholders
5.8.2009 Genesis Research Establishes Solirna Biosciences
24.7.2009 Share Purchase Plan Documents
14.07.2009 Share Purchase Plan Announcement
06.07.2009 Letter to Shareholders
30.06.2009 Annual Meeting Presentation
30.06.2009 Genesis Research Updates Funding Status
15.06.2009 Genesis Research Progressing Funding Discussions
30.04.2009 Genesis Confirms Focus on New Gene Silencing Technology with Significant Potential
26.03.2009 Annual Report 2008
23.02.2009 Financial Statements and Statutory Information
23.02.2009 Full Year Results 13.02.2009 Genesis Research Swaps Royalty Stream for Equity Stake 02.02.2009 Letter to Shareholders 09.01.2009 Genesis Research Announces Settlement Delay
